GSA Capital Partners »

Inovio Pharmaceuticals shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Inovio Pharmaceuticals (INO) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Inovio Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Inovio Pharmaceuticals held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inovio Pharmaceuticals by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.0M 443k 2.34
2025-06-30 $332k 163k 2.03
2024-03-31 $1.1M 80k 13.88

More positions owned by GSA Capital Partners

Accenture Plc Ireland Shs Class A (ACN)
Sprouts Fmrs Mkt (SFM)
Microsoft Corporation (MSFT)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Qorvo (QRVO)
EOG Resources (EOG)
Nuvation Bio Com Cl A (NUVB)
Jefferies Finl Group (JEF)
Frontier Communications Pare (FYBR)
Hldgs (UAL)
Informatica Com Cl A (INFA)
TJX Companies (TJX)
Vital Farms (VITL)
Apple (AAPL)

View all positions for GSA Capital Partners

Top funds holding Inovio Pharmaceuticals

Adage Capital Partners GP
Henderson Group
Vanguard Group
Boxer Capital Management
Millennium Management
Renaissance Technologies
D. E. Shaw & Co
Geode Capital Management
BlackRock
GSA Capital Partners
Morgan Stanley
UBS Group
Two Sigma Investments
Susquehanna International
Northern Trust

View all funds holding Inovio Pharmaceuticals